DeutschNewstral
Article
bizjournals.com on 2022-05-10 13:37
Raleigh drugmaker pursuing Covid treatment raising $15M to fund acquisitions
Related news
- Company sues Raleigh drugmaker over patent -- againbizjournals.com
- Raleigh drugmaker shifts focus after trial setbackbizjournals.com
- Raleigh drugmaker will use $115M for commercialization effortsbizjournals.com
- Raleigh drugmaker being acquired by competitor in $604M dealbizjournals.com
- Raleigh drugmaker with Covid treatment in pipeline expands manufacturing capacitybizjournals.com
- Raleigh drugmaker coming off triple merger reports promising trial databizjournals.com
- Raleigh drugmaker presses forward with potential Covid treatmentbizjournals.com
- Raleigh drugmaker pulls in $200 million – here's what nextbizjournals.com
- Raleigh drugmaker slashes workforce as biotech downturn deepensbizjournals.com
- Raleigh med-tech led by UNC physician raises $15Mbizjournals.com
- WRaleigh drugmaker of 'female Viagra' hopes for FDA approval next weekwraltechwire.com
- Why a Raleigh drugmaker thinks it can raise $100M in 2020bizjournals.com
- Raleigh drugmaker gets a boost from the FDA -- enhancing product's marketabilitybizjournals.com
- Triangle drugmaker plans merger with Israeli pharma -- what it means for Raleighbizjournals.com
ComedyWorx in Raleigh raising money for new locationnewsobserver.com- Raleigh kitchen and bath company grows with 3 acquisitions in 3 monthsbizjournals.com
- Raleigh startup hits $4B valuation, aims to really 'move the needle' on acquisitionsbizjournals.com
- Homebuilding boom, acquisitions streak boost $4 billion Raleigh firm's new ownerbizjournals.com
- Shots from pursuing vehicle injure 2 in car in northwest Raleigh, police reportnewsobserver.com